Access 2.8M+ Filings Sign Up Free
Lidds AB Logo

Lidds AB | LIDDS - Profile, Filings, Stock Info & Investor Relations Data

Lidds AB | LIDDS
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Sweden
Founded
1999
Lidds AB (LIDDS)

Company Profile

About Lidds AB

Lidds AB develops innovative drug delivery technologies for cancer treatment.

Headquarters

Box 12040
112 40, Stockholm
Sweden

Lidds AB (LIDDS)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Get Notified About Lidds AB's New Filings

Receive email alerts when new documents are published.

You can unsubscribe at any time.

Lidds AB (LIDDS)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

↑
Anders Månsson (Other)
Buy SEK 140,000.00 SEK 1.40 14.02.23
↑
Matthew Lindon (Other)
Buy SEK 99,999.20 SEK 1.40 10.02.23
◆
Daniel Lifveredson (Other)
Other SEK 210,000.00 SEK 1.40 09.02.23
↓
Daniel Lifveredson (Other)
Sell SEK 826,982.60 SEK 1.90 16.12.22
↑
Daniel Lifveredson (Other)
Buy SEK 826,982.60 SEK 1.90 16.12.22
↑
Galba Holding AB (Other)
Buy SEK 4,500,000.00 SEK 6.00 02.06.22
↑
Jan Törnell (Other)
Buy SEK 32,500.00 SEK 6.50 08.03.22
◆
Nina Herne (Other)
Other SEK 116,000.00 SEK 1.16 30.06.21
↑
Daniel Lifveredson (Other)
Buy SEK 4,483,116.20 SEK 10.30 03.06.21
↑
Maria Forss (Other)
Buy SEK 29,992.00 SEK 13.04 31.05.21

Lidds AB (LIDDS)
Stock & Investor Information

ISINs

SE0001958612

LEI

549300YYW8B918K7UN72

Industry Classification

Sector
Health Care
Industry
Biotechnology